Rigorous Comparison of Extracellular Vesicle Processing to Enhance Downstream Analysis for Glioblastoma Characterization
Advanced Biology · 2024
DOI: 10.1002/adbi.202300233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biology, 2024. Verfasst von Tiffaney Hsia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA, 02114, USA. Hauptthemen laut MEDLINE: Glioblastoma, Extracellular Vesicles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Rappaport Foundation, Division of Cancer Prevention, National Cancer Institute.
Abstract (Originalsprache)
Extracellular vesicles (EVs) are highly sought after as a source of biomarkers for disease detection and monitoring. Tumor EV isolation, processing, and evaluation from biofluids is convoluted by EV heterogeneity and biological contaminants and is limited by technical processing efficacy. This study rigorously compares common bulk EV isolation workflows (size exclusion chromatography, SEC; membrane affinity, MA) alongside downstream RNA extraction protocols to investigate molecular analyte recovery. EV integrity and recovery is evaluated using a variety of technologies to quantify total intact EVs, total and surface proteins, and RNA purity and recovery. A comprehensive evaluation of each analyte is performed, with a specific emphasis on maintaining user ( n = 2), biological ( n = 3), and technical replicates ( n ≥3) under in vitro conditions. Subsequent study of tumor EV spike‐in into healthy donor plasma samples is performed to further validate biofluid‐derived EV purity and isolation for clinical application. Results show that EV surface integrity is considerably preserved in eluates from SEC‐derived EVs, but RNA recovery and purity, as well as bulk protein isolation, is significantly improved in MA‐isolated EVs. This study concludes that EV isolation and RNA extraction pipelines govern recovered analyte integrity, necessitating careful selection of processing modality to enhance recovery of the analyte of interest.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA, 02114, USA.
- Center for Systems Biology, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA, 02114, USA.
- Department of Radiology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.
- Department of Neurosurgery, Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.
ORCID-Profile: Leonora Balaj
Förderung
- NCI NIH HHS
- Rappaport Foundation
- Division of Cancer Prevention, National Cancer Institute
Zitieren
APA
Hsia, T., You, D. G., Politis, M. G., Batool, S. M., Ekanayake, E., Lee, H., Carter, B. S., & Balaj, L. (2024). Rigorous Comparison of Extracellular Vesicle Processing to Enhance Downstream Analysis for Glioblastoma Characterization. Advanced Biology. https://doi.org/10.1002/adbi.202300233
Vancouver
Hsia T, You DG, Politis MG, Batool SM, Ekanayake E, Lee H, et al. Rigorous Comparison of Extracellular Vesicle Processing to Enhance Downstream Analysis for Glioblastoma Characterization. Advanced Biology. 2024. doi:10.1002/adbi.202300233
BibTeX
@article{Hsia2024,
author = {Hsia, Tiffaney and You, Dong Gil and Politis, Michelle Garlin and Batool, Syeda Maheen and Ekanayake, Emil and Lee, Hakho and Carter, Bob S and Balaj, Leonora},
title = {Rigorous Comparison of Extracellular Vesicle Processing to Enhance Downstream Analysis for Glioblastoma Characterization},
journal = {Advanced Biology},
year = {2024},
doi = {10.1002/adbi.202300233}
}
EUVIMED